A stem (100) for use in a joint prosthesis, such as a femoral stem for a hip joint prosthesis, the stem comprising: a solid central core (102); a proximal outer layer (127) disposed over a proximal portion (101a) of the central core, wherein the proximal outer layer comprises a set of longitudinal ribs (120), defining slots (130) there between; and a distal outer layer made of a deformable porous material disposed over a distal portion (101b) of the central core. The arrangement is such that the stem (100) can be made with a relatively large diameter yet without being excessively stiff, for cementless fixation in osteoporotic patients. The deformability of the distal outer layer also mitigates against the risk of intraoperative bone fractures.

The invention relates to a device intended to replace or partially replace one or more vertebral bodies or intervertebral discs in the cervical, thoracic or lumbar spine, and includes methods for its use and deployment. The invention may be used to restore biomechanical parameters correlating with improved patient outcomes and also involves a method for a more effective discectomy or corpectomy prior to graft deployment.

Implantable drug-eluting device (1) comprising a microporous structure (2) having regularly arranged pores (4, 5) in at least two different uniform sizes, and manufacturing method. The pores are configured for receiving a drug (9) and are being connected by interconnections (6, 7). Interconnections (6) originating from pores (4) of a first size have a first elution area and interconnections (7) originating from pores (5) of a second size have a second elution area. The interconnections convey the drug (9) to a surface of the device for elution to surrounding tissue. The ratio between the first and the second elution areas is predefined and selectable. The differently sized elution areas provide for different outflow rates. This allows for simple but reliable dispensing of drugs at positively controlled and well determined rates. Particularly, this enables a single implantable device to dispense drugs over preselectable durations of time, like short-term or long-term.

An artificial articulation having stable fixing means for unicompartmental knee arthroplasty is stably attached to the top of a tibia in order to permit a sliding motion of an artificial joint attached to the bottom of a femur. The artificial articulation includes an implant hat part which a curved surface structure that makes surface contact with the artificial joint attached to the bottom of the femur is formed on an upper surface thereof, and protrusions protruding by a predetermined height in a direction of the top of the tibia are formed in large numbers on a lower surface thereof, and a distally extending stem configured to be formed to protrude downward by a predetermined length from the lower surface of the implant hat part, and to be inserted into the tibia by a predetermined depth from the top of the tibia and attached thereto.

A sleeve for use with a percutaneous, external fixation device is disclosed, wherein the sleeve includes a sleeve body with an interior space in which the percutaneous device can be disposed, a flange that extends at a substantially perpendicular angle to the sleeve body, and a cutting edge extending from the sleeve body below the flange. The cutting edge is designed for placement in contact with the skin adjacent to the percutaneous device so as to define a leading edge thereof in a primary anticipated direction of migration of the percutaneous device. Kits and assemblies that include sleeves and percutaneous devices are also disclosed. Further disclosed are methods of reducing tension in a patient's skin following placement of the percutaneous device via use of the sleeve, as well as methods of adjusting and readjusting the assembly upon placement.

The present invention disclosed a method of producing a three-dimensional porous tissue in-growth structure. The method includes the steps of depositing a first layer of metal powder and scanning the first layer of metal powder with a laser beam to form a portion of a plurality of predetermined unit cells. Depositing at least one additional layer of metal powder onto a previous layer and repeating the step of scanning a laser beam for at least one of the additional layers in order to continuing forming the predetermined unit cells. The method further includes continuing the depositing and scanning steps to form a medical implant.

An orthopedic system for delivery of a therapeutic agent to a bone includes an elongate stem adapted to be inserted into an intramedullary canal, an inlet configured to receive the therapeutic agent, and one or more outlets configured to deliver the therapeutic agent to the bone. The elongate stem may comprise one or more protrusions to engage the bone, and one or more channels extending longitudinally therein, fluidly coupled to the inlet. The therapeutic agent flows from the inlet through the one or more channels and exits into the intramedullary canal through the one or more outlets. The system may be configured to allow one or more dimensions of the system to be adjusted to accommodate the anatomy of a patient.

A bone implant holding and shaping tray is provided. The tray includes a first segment having a distal end and a first surface sized to hold and shape at least a portion of the bone implant with bone material. The tray includes a second segment having a second surface sized to hold and shape at least a portion of the bone implant with bone material, the second segment having a proximal end configured to be coupled to the distal end of the first segment so as to extend the first surface to hold and shape the bone implant. Methods of making and using the bone implant holding and shaping tray are also provided.

An orthopedic system for delivery of a therapeutic agent to a bone includes an elongate stem adapted to be inserted into an intramedullary canal, an inlet configured to receive the therapeutic agent, and one or more outlets configured to deliver the therapeutic agent to the bone. The elongate stem may comprise one or more protrusions to engage the bone, and one or more channels extending longitudinally therein, fluidly coupled to the inlet. The therapeutic agent flows from the inlet through the one or more channels and exits into the intramedullary canal through the one or more outlets. The system may be configured to allow one or more dimensions of the system to be adjusted to accommodate the anatomy of a patient.

The three-dimensional lattice structures disclosed herein have applications including use in medical implants, Some examples of the lattice structure are structural in that they can be used to provide structural support or mechanical spacing In some examples, the lattice can be configured as a scaffold to support bone or tissue growth Some examples can use a repeating modified rhombic dodecahedron or radial dodeca-rhombus unit cell. The lattice structures are also capable of providing a lattice structure with anisotropic properties to better suit the lattice for its intended purpose.